About certus molecular diagnostics
certus molecular diagnostics is a company based in Zollikofen (Switzerland) founded in 2017. certus molecular diagnostics offers products and services including Molecular Rapid Tests. certus molecular diagnostics operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Zollikofen, Switzerland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Certus Molecular Diagnostics Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of certus molecular diagnostics
certus molecular diagnostics offers a comprehensive portfolio of products and services, including Molecular Rapid Tests.
Rapid tests for detecting pathogens with 30-minute results and simple use.
Funding Insights of certus molecular diagnostics
Detailed funding history for certus molecular diagnostics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by certus molecular diagnostics
Investment portfolio details for certus molecular diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - certus molecular diagnostics
Detailed financials for certus molecular diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Certus Molecular Diagnostics Comparisons
Peer comparison for certus molecular diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of certus molecular diagnostics
certus molecular diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| Locked | Locked | Locked |
Diagnostic technologies for infectious, cancer, and neurological diseases are developed.
|
Detailed competitors of certus molecular diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Certus Molecular Diagnostics
Complete news archive for certus molecular diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about certus molecular diagnostics
certus molecular diagnostics was founded in 2017.
certus molecular diagnostics is headquartered in Zollikofen, Switzerland. It is registered at Zollikofen, Bern, Switzerland.
Certus Molecular Diagnostics was founded in 2017 and is based in Zollikofen, Switzerland. Operations focus on the molecular diagnostics sector, where rapid tests for identifying specific genes in microorganisms are developed and supplied. A proprietary isothermal amplification method combined with real-time detection is utilized. Ready-to-use reagents are offered, enabling targeted gene segments to be amplified isothermally and detected via a dsDNA-intercalating dye.
certus molecular diagnostics's top competitors include Visby Medical, Inflammatix and MeMed.
certus molecular diagnostics offers Molecular Rapid Tests.